IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023

IAS 2023，第 12 届 IAS HIV 科学会议，澳大利亚布里斯班，虚拟会议，2023 年 7 月 23-26 日

• 批准号: 10696505
• 负责人: Christopher C. Beyrer
• 金额: $ 75万
• 依托单位: IAS
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-05-01 至 2024-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10696505
• 关键词: 2019-nCoV; AIDS prevention; Acceleration; Acquired Immunodeficiency Syndrome; Address; Affect; Antibody Response; Antiviral Agents; Area; Asia; Attention; Australia; Basic Science; Behavioral; Behavioral Sciences; COVID-19; COVID-19 impact; COVID-19 pandemic; COVID-19 pandemic effects; Caring; Clinic; Clinical; Clinical Sciences; Communities; Competence; Complex; Consensus; Country; Couples; Development; Discrimination; Disease remission; Economics; Emergency response; Ensure; Epidemic; Epidemiology; Formulation; Fostering; Geography; Goals; Guidelines; HIV; HIV Infections; HIV vaccine; Health; Health Personnel; Health system; Human; Human immunodeficiency virus test; Hybrids; Immunology; Improve Access; Incidence; Individual; Infection; Infrastructure; International; International AIDS; Intervention; Knowledge; Leadership; Life; Messenger RNA; Methods; Minority; Monkeypox; Outcome; Outcomes Research; Participant; Pathogenesis; Personal Satisfaction; Persons; Pharmaceutical Preparations; Policies; Policy Maker; Politics; Population; Populations at Risk; Prevention; Prevention Research; Prevention approach; Prevention program; Private Sector; Public Health; RNA vaccine; Research; Research Personnel; Resource-limited setting; Rights; Scholarship; Science; Scientist; Social Sciences; Stigmatization; Structure; System; Technology; Testing; Translating; Treatment outcome; Vaccines; Viral; Viral hepatitis; Work; base; civil society; co-infection; comorbidity; cost effective; design; exhibitions; experience; forging; gender diversity; gene therapy; implementation barriers; implementation research; implementation science; improved; indigenous community; innovation; insight; interdisciplinary collaboration; low and middle-income countries; marginalization; marginalized population; meetings; member; men who have sex with men; multidisciplinary; neutralizing antibody; novel; pandemic disease; pandemic preparedness; patient oriented; person centered; posters; precision medicine; prevention practice; programs; public health emergency; response; scale up; sex; social; social health determinants; social stigma; success; symposium; synergism; transmission process; uptake; vaccinology; viral pandemic; virology; virtual

Project Summary IN 2021 UNAIDS estimated the HIV incidence to have been 1.5 million new infections, while the 2020 target was set to be under 500,000 global infections for that year. At this rate, the HIV response is sharply off target to achieve the goal of an end to the pandemic as the global public health threat by 2030. The COVID-19 pandemic has severely affected the HIV response as it has caused consequential disruption in the HIV response, HIV testing and prevention. Furthermore, with WHO’s declaration of Monkeypox as a public health emergency of international concern, and this new emergence currently occurring overwhelmingly among men who have sex with men, a community with a very high burden for HIV, there are currently three concurrent pandemics underway challenging human health and wellbeing, health systems, and fragile public health infrastructures worldwide. IAS 2023 must address HIV science in the context of a wider pandemic preparedness and with a view toward the impacts of COVID-19 and Monkeypox on persons living with HIV, and on health systems and providers. Vaccine science will be prominent, as well as antiviral agents and their interactions for all three of these viral pandemics. Accelerate basic science and clinical science innovation in the development and application of person-centered precision medicine for HIV treatment, reducing HIV transmission, vaccines, pathogenesis, co-infections, and the search for a cure will feature prominently at IAS 2023. Specific aims of IAS 2023 will be to: 1. Advance inter-disciplinary collaboration in implementation research to reduce HIV transmission and improve treatment outcomes across all life-stages with a special focus on translating research outcomes into policy and practice through simplified practical guidelines for low- and middle-income countries and key populations. 2. Strengthen HIV prevention research to improve cost-effective biomedical, behavioral and structural interventions with a special focus on understanding implementation challenges, overcoming system barriers and replicating successes in HIV prevention practice and programs. 3. Address HIV vulnerability, determinants of HIV burdens and poor clinical outcomes among key and marginalized populations, including interventions to reduce stigma and discrimination and improve access and uptake of ART for prevention and treatment with a special focus on First Nations and Indigenous communities and on person-centered approaches. 4. Re-engage and reenergize community, clinical, social and political efforts to address unmet HIV needs and strengthen HIV policy in the Asia-Pacific region in the COVID-19 era, paying special attention to the needs of marginalized First Nations and Indigenous communities. The scientific program will be structured along five scientific tracks: basic science; clinical science; epidemiology & prevention science; social and behavioural sciences; implementation science, economics, systems and synergies. Topics to be addressed in each thematic area are described below. The scientific program is developed by a multi-disciplinary international Organizing Committee whose members are selected on the bases of scientific, policy and implementation expertise, meaningful engagement and representation of key and affected populations, of civil society and / or young people and geographic and gender diversity as key competencies and attributes ensuring diversity at all levels. Cross-cutting aspects will be highlighted in plenary talks that also connect the science with community and leadership perspectives. Additionally, bridging sessions are designed to cut across the different thematic areas to provide opportunities for multi-disciplinary, multi- perspective dialogues, often using interactive formats. Building on the success of the 24th International AIDS Conference - AIDS 2022 in hybrid format, IAS 2023 will be held in-person and virtually, providing many opportunities for discussions, debates and interconnection between the in-person and virtual speakers and audiences. Expected attendance is 6,000 HIV scientists, clinicians, policy makers, and program implementers as well as civil society, community and private sector representatives (4,500 in person and 1,500 online). IAS 2023 will provide scholarships to ensure the full participation of researchers, community activists and civil society representatives, especially those from resource-limited settings and underrepresented communities. Guided by best practices, the hybrid format will maximize inclusive conference experiences for all stakeholders at all levels.

项目摘要 在2021年，联合国署估计艾滋病毒事件为150万新感染，而2020年的目标是 该年的全球感染将低于500,000。以这种速度，艾滋病毒的反应恰恰是 到2030年，将大流行作为全球公共卫生威胁的目的。 19009年大流行严重影响了艾滋病毒的反应 艾滋病毒反应，艾滋病毒测试和预防。此外，谁宣布蒙基托克斯为公众 国际关注的卫生紧急情况，以及目前绝大多数发生的新紧急情况 与男人发生性关系的男人，一个艾滋病毒烧伤很高的社区，目前有三个并发 大流行者正在挑战人类健康和福祉，卫生系统以及脆弱的公共卫生 全球基础设施。 IAS 2023必须在更广泛的大流行准备的背景下解决HIV科学 并考虑到Covid-19和Monkeypox对艾滋病毒和健康的人的影响 系统和提供商。疫苗科学将是突出的，抗病毒剂及其相互作用 这三个病毒大流行。加速发展基础科学和临床科学创新 以及以人为中心的精密药物在HIV治疗中的应用，减少艾滋病毒传播，疫苗， 发病机理，共同感染和寻找治愈的搜索将在IAS 2023上突出。 IAS 2023的具体目标将是： 1。在实施研究方面提前学科合作，以减少艾滋病毒传播和改善 在所有生命阶段的治疗结果，特别关注将研究成果转化为政策 并通过简化的低收入和中等收入国家和关键的实用准则实践 人群。 2。加强艾滋病毒预防研究以改善具有成本效益的生物医学，行为和结构 干预措施特别关注理解实施挑战，克服系统障碍 并复制艾滋病毒预防实践和计划中的成功。 3。解决艾滋病毒脆弱性，确定艾滋病毒伯恩斯和关键和临床效果不佳 边缘化的人群，包括减少污名和歧视的干预措施并改善访问权限 并特别关注原住民和土著的艺术品用于预防和治疗 社区和以人为本的方法。 4。重新参与并重新激发社区，临床，社会和政治努力，以满足未满足的艾滋病毒需求和 加强在共同19时代亚太地区的艾滋病毒政策，特别注意需求 边缘化的原住民和土著社区。 科学计划将沿五个科学轨道构建：基础科学；临床科学；流行病学 ＆预防科学；社会和行为科学；实施科学，经济学，系统和 协同作用。下面描述了每个主题领域中要解决的主题。科学计划是 由多学科国际组织委员会开发 科学，政策和实施专业知识，有意义的参与以及密钥的代表 受影响的人群，民间社会和 /或年轻人以及地理和性别多样性作为关键 能力和属性确保各级多样性。全体会议将突出显示横切方面 谈判也将科学与社区和领导力的观点联系起来。另外，桥接会议 旨在削减不同主题领域，以提供多学科，多学科的机会 透视对话，通常使用交互式格式。 在第24届国际艾滋病会议的成功基础上 - 艾滋病2022的混合形式，IAS 2023 亲自举行，实际上是为讨论，辩论和互连提供了许多机会 在面对面和虚拟演讲者和听众之间。预期出勤是6,000名艾滋病毒科学家， 临床医生，政策制定者和计划实施者以及民间社会，社区和私营部门 代表（亲自4,500，在线1,500）。 IAS 2023将提供科学，以确保完整 研究人员，社区活动家和民间社会的参与代表，特别是 资源有限的设置和代表性不足的社区。在最佳实践的指导下，混合格式将 为所有级别的所有利益相关者最大化包容性会议经验。